Both vaccines work. But Pfizer requires a longer waiting period before the vaccine kicks in, while Moderna has stronger side effects.

Shares in Pfizer and Moderna fell 3.9% and 7.4%, respectively, Friday after a report that the Trump administration plans to link the deaths of 25 children to COVID vaccines. Trump health officials ...

BAYER’S Monsanto sued Covid-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for allegedly misusing its messenger RNA technology in manufacturing their vaccines, a ...

Stocks of COVID-19 vaccine makers take a dive following Washington Post report, while Moderna stresses multiple agencies have backed their safety Stocks of COVID vaccine makers dropped after the ...

The JN.1 Novavax vaccine is an alternative to the LP.8.1 Pfizer-BioNTech and Moderna vaccines that were rolled out in October ...

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...

Nov 20 (Reuters) - Moderna (MRNA.O), opens new tab said on Thursday it secured a five-year loan of $1.5 billion from Ares Management (ARES.N), opens new tab, as it targets up to 10% revenue growth ...

Pfizer, BioNTech request EU conditional approval Regulator says panel to meet Dec 29 at latest Rival Moderna also submits EU filing for its shot Both groups have applied for U.S. emergency use ...

Shares of companies that make COVID-19 vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths. The Washington Post ...

(Reuters) -Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management, as it targets up to 10% revenue growth next year. The vaccine maker, which is expected to unveil ...